1. Biosolv - Biosytes (Goldman) - Q-Gel®

U.S. Patent No. 6,056,971 (Expires July 23, 2017)

2. Enhanced Bioavailablility of CoQ10

U.S. Patent No. 6,300,377 (Raj Chopra) - "Hyrdosolv" (Expires February 22, 2021)

3. Composition of palatable Oral CoQ10 Liquid

U.S. Patent No. 6,441,050 (Raj Chopra) - "Opti-solv" (Expires August 29, 2029)

4. Q-Nol® (Reduced CoQ10)

U.S. Patent No. 6,740,338 (Raj Chopra) - "Q-Nol" (Expires May, 2024)

5. Reduced Form of Coenzyme Q10 in High Bioavailability - stable dosage forms and related applications

Canadian Patent No. 2,397,447 (Raj Chopra) - "Q-Nol" (Expires January 18, 2021)

6. Palatable Oral Coenzyme Q10 Liquid

Canadian Patent No. 2,417,289 (Raj Chopra) - "Q-Nol" (Expires August 17, 2021)

7. HydroQsorb

U.S. Patent No. 6,861,447 (Wacker)

8. LiQsorb

U.S. Patent No. 6,455,072 (3i)

9. Bioslov - Biosytes (Goldman) - Q-Gel®

Canadian Patent No. 2,236,023

CoQ10 Product Sheets

Click on any of the images below to download a PDF version of our product sheets

Looking to enhance your existing product line or create a new one?

The applications for the Q-Gel® product line have an extended reach. Tishcon Corp., one of the leaders in Coenzyme Q10 (CoQ10) research, education and contract manufacturing can provide all our products in bulkpacks or labeled in consumer packages to your specifications.

Contact Tishcon